bonviva tablet 2.5mg
roche singapore pte. ltd. - ibandronic acid (ibandronate form) - tablet, film coated - 2.5mg (2.813mg)
bonviva 150 mg film-coated tablet
atnahs pharma uk ltd.; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - ibandronic acid - film-coated tablet - 150 mg
bonviva 150 mg f.c. tablets film-coated tablet
atnahs pharma uk limited, united kingdom - ibandronic acid - film-coated tablet - 150 mg
bonviva 150 mg
roche products sa (pty) ltd - ibandronic acid - tablets - each film-coated tablet contains ibandronate monosodium monohydrate equiv. to ibandronic acid 150,0mg
bonviva 2,5 mg
roche products sa (pty) ltd - ibandronic acid - tablets - each film-coated tablet contains ibandronate monosodium monohydrate equiv. to ibandronic acid 2,5mg
bonviva 150 mg f.c. tablets film-coated tablet
atnahs pharma uk limited, united kingdom - ibandronic acid - film-coated tablet - 150 mg
bonviva 150mg tablets
atnahs pharma uk ltd - ibandronic sodium monohydrate - tablet - 150mg
bonviva
roche products (nz) ltd - ibandronate sodium monohydrate 2.813mg equivalent to ibandronic acid 2.5 mg; - film coated tablet - 2.5 mg - active: ibandronate sodium monohydrate 2.813mg equivalent to ibandronic acid 2.5 mg excipient: colloidal silicon dioxide crospovidone hypromellose/titanium dioxide/talc (60.5%/29%/10.5%) lactose monohydrate macrogols microcrystalline cellulose povidone stearic acid
bonviva pre-filled syringe 3mg3ml
dksh singapore pte. ltd. - ibandronic acid (as monosodium monohydrate 3.375mg) - injection, solution - 3mg/3ml - ibandronic acid (as monosodium monohydrate 3.375mg) 3mg/3ml
bonviva tablet
atnahs pharma uk ltd. sovereign house, miles gray road, basildon, essex - ibandronic - tablet - ibandronic 150mg - drugs affecting bone structure and